Zusammenfassung
Die Therapieoptionen beim Vestibularisschwannom sind in den letzten Jahren deutlich vielseitiger geworden. Neben die vormals dominierenden operativen Behandlungsmethoden traten strahlentherapeutische Verfahren und auch die sog. Wait-and-scan-Strategie, die jegliche Intervention zunächst vermeidet. Dies macht die Festlegung des Prozedere schwieriger und legt nahe, sie auf eine interdisziplinäre Basis zu stellen. Dies gilt in besonderem Maß auch für Patienten, die an einer Neurofibromatose Typ 2 leiden. Auch die Rehabilitation, deren Schwerpunkt im auditorischen, vestibulären, motorischen und neurologischen Bereich liegt, verlangt eingehende Erfahrung mit dieser komplexen Erkrankung.
Abstract
During the past few decades, therapeutic options in vestibular schwannoma have become more versatile. The former dominant surgical strategies are complemented by radiotherapeutic procedures and the so-called wait-and-scan option. Therefore, the decision to proceed has become more difficult and individual solutions should be found on an interdisciplinary basis. In particular, patients suffering from neurofibromatosis type 2 should be discussed in an experienced center. Furthermore, rehabilitation of auditory, vestibular, motoric, and neurologic functions requires extended experience in this complex disease.
Literatur
Maier W, Grauvogel TD, Laszig R, Ridder GJ (2011) Wertigkeit unterschiedlicher Methoden zur Behandlung von Akustikusneurinomen. HNO 59:425–436
Jackler RK, Whinney D (2001) A century of eighth nerve surgery. Otol Neurotol 22:401–416
Backous DD, Pham HT (2007) Guiding patients through the choices for treating vestibular schwannomas: balancing options and ensuring informed consent. Otolaryngol Clin North Am 40:521–540
Meyer TA, Canty PA, Wilkinson EP et al (2006) Small acoustic neuromas: surgical outcomes versus observation and radiation. Otol Neurotol 27:380–392
Colletti V, Fiorino F (2003) Middle fossa versus retrosigmoid-transmeatal approach in vestibular schwannoma surgery: a prospective study. Otol Neurotol 24:927–934
House WF (1961) Surgical exposure of the internal auditory canal and its contents through the middle cranial fossa. Laryngoscope 71:1363–1385
Baier G, Schwager K, Helms J, Hagen R (2008) Ergebnisse otochirurgisch operierter Patienten mit Akustikusneurinom. Teil 1: Fazialisfunktion nach translabyrinthärer und transtemporaler Resektion. Laryngo Rhino Otol 87:565–572
Wigand ME, Rettinger G, Haid T, Berg M (1985) Die Ausräumung von Octavusneurinomen des Kleinhirnbrückenwinkels mit transtemporalem Zugangüber die mittlere Schädelgrube. HNO 33:11–16
Gjuric M, Rudic M (2008) What is the best tumor size to achieve optimal functional results in vestibular schwannoma surgery? Skull Base 18:317–325
Pellett W (2008) History of vestibular schwannoma surgery. Prog Neurol Surg 21:6–23
Schipper J, Lohnstein P, Stummer W et al (2009) Modifizierter retrolabyrinthärer Zugangsweg bei Kleinhirnbrückenwinkeltumoren zum Hörerhalt. Laryngo Rhino Otol 89:84–89
McKennan KX (1993) Endoscopy of the internal auditory canal during hearing conservation acoustic tumor surgery. Am J Otol 14:259–262
Maier W, Aschendorff A, Laszig R (2007) The value of endoscopic procedures in vestibular schwannoma surgery. In: Garcia-Ibanez E, Tran Ban Huy P (Hrsg) Proceedings of the 5th International Conference on Vestibular Schwannoma and other CPA lesions. Medimond, Bologna, S 221–224
Unger F, Dominikus K, Haselsberger K (2011) Stereotaktische Radiochirurgie und Radiotherapie bei Akustikusneurinomen. HNO 59:31–37
Kopp C, Fauser C, Müller A et al (2011) Stereotactic fractionated radiotherapy and linac radiosurgery in the treatment of vestibular schwannoma – report about both methods from a single institution. Int J Radiat Oncol Biol Phys 80:1485–1491
Yoshimoto Y (2005) Systematic review of the natural history of vestibular schwannoma. J Neurosurg 103:59–63
Bance M, Ramsden R (1999) Management of neurofibromatosis type 2. Ear Nose Throat J 78: 91–96
Samii M, Gerganov V, Samii A (2008) Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results. In: Régis J, Roche PH (Hrsg) Modern management of acoustic neuroma. Karger, Basel, S 169–175
Combs SE, Welzel T, Schulz-Ertner D et al (2010) Differences in clinical results after linac-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 76:193–200
Schwager K (2011) Therapie des Akustikusneurinoms (Vestibularisschwannoms) aus der Sicht der HNO-Heilkunde. HNO 59:22–30
Laszig R, Marangos N, Sollmann WP, Ramsden R (1999) Central electrical stimulation of the auditory pathway in neurofibromatosis type 2. Ear Nose Throat J 78:110–117
Nevison B, Laszig R, Sollmann WP et al (2002) Results from a European clinical investigation of the nucleus multichannel auditory brainstem implant. Ear Her 23:170–183
Khrais T, Sanna M (2006) Hearing preservation surgery in vestibular schwannoma. J Laryngol Otol 120:366–370
Schick U, Unterberg A (2011) Akustikusneurinome (Vestibularisschwannome): Behandlung aus neurochirurgischer Sicht. HNO 59:18–21
Combs SE, Thilmann C, Debus J, Schulz-Ertner D (2006) Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas. Int J Radiat Oncol Biol Phys 64:1341–1347
Kim CH, Kim DG, Paek SH et al (2011) Efficacy of corticosteroids in hearing preservation after radiosurgery for vestibular schwannoma: a prospective study. Stereotact Funct Neurosurg 89:25–33
Brooker JE, Fletscher JM, Dally MJ et al (2010) Quality of life among acoustic neuroma patients managed by microsurgery, radiation, or observation. Otol Neurotol 31: 977–984
Bassim MK, Berliner KI, Fisher LM et al (2010) Radiation therapy for the treatment of vestibular schwannoma: a critical evaluation of the state of the literature. Otol Neurotol 31:567–573
Roehm PC, Gantz BJ (2007) Management of acoustic neuromas in patients 65 years older. Otol Neurotol 28:708–714
Freeman SRM, Ramsden RT, Saeed SR et al (2007) Revision surggery for residual or recurrent vestibular schwannoma. Otol Neurotol 28:1076–1082
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maier, W., Hassepaß, F., Aschendorff, A. et al. Vestibularisschwannom. HNO 60, 927–938 (2012). https://doi.org/10.1007/s00106-012-2534-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-012-2534-x